Ureteral Stents Market Latest Innovations and Key Events in The Industry
The global ureteral
stents market is projected to grow at a steady pace during the forecast
period, owing to the rising cases of kidney transplants, increasing incidence
of urological diseases, and growing geriatric population. On the basis of
product, the market is categorized into open-end, closed-end, double-pigtail,
multiloop, and other stents. Among these, double-pigtail stents are estimated
to hold the largest share in the market in 2017. The market for multiloop
stents, however, is predicted to undergo to grow at the highest rate because of
the increase in the prevalence of urological disorders, rise in geriatric
population, and technological advancements in multiloop stents leading to
reduced complications.
On the basis of end user, the ureteral stents market is
categorized into hospitals, clinics, and ASCs. During the forecast period, ASCs
are expected to lead the market, in terms of both size and growth. During the
historical period, North America held the largest share in the ureteral stents
industry, because of the availability of advanced medical facilities and high
prevalence of kidney stone problems in the region. However, during the forecast
period, Asia-Pacific is expected to grow at the highest CAGR, because of the
surging population, increasing medical awareness on these stents, growing
prevalence of urological diseases, increasing initiatives of the government for
the improvement of healthcare, and rising disposable income of the people in the
region.
Request to Get the Sample Pages at:
According to the United States Renal Data System (USRDS),
around 17,600 kidney transplants were performed in the U.S. in 2013. From 2012
to 2013, there was a 3.1% increase in the cumulative number of recipients with
a functioning kidney transplant. As of December 31, 2013, the kidney transplant
waiting list increased by 3%, from the previous year, to 86,965 candidates
(dialysis patients only), 83% of whom awaited their first kidney transplant.
Some of the major players in the ureteral
stents market are Becton, Dickinson and Company; Cook Medical LLC; B.
Braun Melsungen AG; Olympus Corporation; Coloplast A/S; Medline Industries
Inc.; Allium Medical Solutions Ltd.; Teleflex Incorporated; Boston Scientific
Corporation; and Pnn Medical A/S.
For instance, in March 2016, Boston Scientific Corporation
launched a new app, called the Ureteral Stent Tracker, to help urologists and
their staff keep tabs on ureteral stents implanted in patients with kidney
stones. The app was developed in partnership with the health app developer
Visible Health Inc.
Comments
Post a Comment